Skip to content

Occipital Nerve Stimulation in Fibromyalgia

Subcutaneous C2 Stimulation: Treatment of Fibromyalgia

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00917176
Enrollment
Unknown
Registered
2009-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2009-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Brief summary

The aim of this study is to investigate whether greater occipital nerve stimulation is effective in the treatment of fibromyalgia related pain. The study uses sub sensory threshold stimulation and placebo stimulation in order to investigate whether sub-threshold stimulation is feasible in a placebo controlled study.

Interventions

Sponsors

University Hospital, Antwerp
Lead SponsorOTHER

Study design

Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed according to the criteria of the American College of Rheumatology (ACR-90) * Minimally treated with adequate trials during 3 months * Insight of the patient in her disease and capable of understanding and signing an informed consent

Exclusion criteria

* History of severe illness or suffering from severe chronic disease * History of substance abuse, unless treated and in remission during 6 months * Cardiac disease * History of epileptic insults * Psychiatric disorders with psychotic symptoms * Pace maker / defibrillator * Pregnancy

Design outcomes

Primary

MeasureTime frame
Pain scores on Visual Analogue Scale (VAS), pain Catastrophizing Scale (PCS), pain vigilance and awareness questionnaire (PVAQ)at a weekly base during 10 weeks

Secondary

MeasureTime frame
Scores on Fatigue and Moodat a weekly base, during 10 weeks

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026